Abcuro announces pre-clinical data on new immuno-oncology target
Member News

Related or similar articles

June 18, 2024
Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development
Labshares appoints a Devon Lagasse as VP of Growth and promotes Emma Orfanos to Manager of Business Development, strengthening its leadership as the Greater Boston shared lab provider expands.
Press Releases

September 3, 2026
K2B Therapeutics: Journey from Incubator to Labshares
Learn how K2B Therapeutics transitioned from the traditional incubator model to Labshares. The team was fully operational in less than 2 weeks, and now has the flexibility and support to continue growing.
Blog Posts

May 12, 2025
Leasing / Subleasing vs. Shared Labs: Why Labshares is the Capital-Efficient Choice for Biotechs
Shared labs offer emerging biotechs a flexible, capital-efficient alternative to leasing or subleasing. Labshares combines lab space, advanced equipment, and operational support with 60-70% cost savings.
Blog Posts